Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism
- 1 June 1995
- journal article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 80 (6) , 1816-1821
- https://doi.org/10.1210/jc.80.6.1816
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: